| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.5 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |